EXHIBIT 7.11Purchase Agreement • March 22nd, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • New York
BY AND AMONG AMGEN INC.,Agreement and Plan of Merger • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 1.1 UNDERWRITING AGREEMENTUnderwriting Agreement • December 5th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 2.2 FIRST AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER FIRST AMENDMENT TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER, dated as of July 15, 2002 (this "First Amendment"), by and among Amgen Inc., a Delaware corporation...Agreement and Plan of Merger • July 15th, 2002 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 24th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • California
Amgen Inc. andRights Agreement • December 18th, 2000 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMGEN INC.Terms Agreement • December 9th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 1 TO WARRANT AGREEMENTWarrant Agreement • March 7th, 2000 • Amgen Inc • Biological products, (no disgnostic substances) • New York
OFLicense Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 99.7 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement"), made and entered into as of the Effective Date (as hereinafter defined), between Amgen Inc., a Delaware corporation (the "Company"), and Edward V. Fritzky (the...Employment Agreement • January 31st, 2002 • Amgen Inc • Biological products, (no disgnostic substances) • Washington
EXHIBIT 7.3 =================================================================== ============= REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 4 TO -- SHAREHOLDERS' AGREEMENT ----------------------- OF -- KIRIN-AMGEN, INC. -----------------Assignment Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
AGREEMENT ---------Rights Agreement • February 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Amgen Inc. andRights Agreement • February 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 2 _ --------------- _TOLicense Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Page ARTICLE 1 DEFINITIONS AND ACCOUNTING TERMS................ 1 -------------------------------- 1.1 Defined Terms.............................................. 1 ------------- 1.2 Use of Defined Terms....................................... 18...Credit Agreement • August 14th, 1998 • Amgen Inc • Biological products, (no disgnostic substances) • California
ARTICLE 1 DEFINITIONS AND ACCOUNTING TERMSCredit Agreement • August 6th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
by and betweenLicense Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
between AMGEN INC. andRegistration Rights Agreement • November 19th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.68 RESTRICTED STOCK PURCHASE AGREEMENT JOSEPH P. MILETICH, Amgen Inc. Grantee: On this 1st day of April, 2002, Amgen Inc., a Delaware corporation (the "Company"), pursuant to its Amended and Restated 1991 Equity Incentive Plan (the "Plan")...Restricted Stock Purchase Agreement • April 29th, 2002 • Amgen Inc • Biological products, (no disgnostic substances)
AMGEN INC.Purchase Agreement • November 19th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.43 May 10, 2000 Mr. Gordon M. Binder 130 Delfern Drive Los Angeles, CA 90077 Re: Agreement Regarding Part-Time Special Assignment Position --------------------------------------------------------- Dear Gordon: On behalf of Amgen Inc....Amgen Inc • August 1st, 2000 • Biological products, (no disgnostic substances) • California
EXHIBIT 7.1 =================================================================== ============= STOCK AND WARRANT PURCHASE AGREEMENTStock and Warrant Purchase Agreement • October 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Annex D RESTRICTED STOCK UNIT AGREEMENT _____________________, Amgen Inc. Grantee: On this __ day of _______________ (the "Grant Date"), Amgen Inc., a Delaware corporation (the "Company"), pursuant to its Director Equity Incentive Program (the...Restricted Stock Unit Agreement • March 11th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
WHEREAS, as of the date hereof, each Shareholder "beneficially owns" (as such term is defined in Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) and is entitled to dispose of (or to direct the disposition of) and to vote...Shareholder Voting Agreement • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 7Shareholders' Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
Exhibit 10.56 July 19, 2001 Dr. George Morstyn 964 Bright Star Thousand Oaks, CA 91360 Re: Agreement Regarding Part-Time Special Assignment Position --------------------------------------------------------- Dear George: On behalf of Amgen Inc....Entire Agreement • October 26th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.52 ASTERISKS (*) INDICATE CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH THE SEC. HEADS OF AGREEMENTHeads of Agreement • August 12th, 1997 • Amgen Inc • Biological products, (no disgnostic substances)
AMGEN INC. One Amgen Center Drive, Thousand Oaks, CA 91320-1799 Proxy Solicited by Board of Directors For the Special Meeting of Stockholders to be Held on _________, 2002Amgen Inc • January 31st, 2002 • Biological products, (no disgnostic substances)
AMGEN INC. ANDAmgen Inc • March 14th, 1997 • Biological products, (no disgnostic substances) • New York
Registration Rights Agreement Dated As of February 17, 2006 between Amgen Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. IncorporatedRegistration Rights Agreement • February 21st, 2006 • Amgen Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into this 17th day of February, 2006, among Amgen Inc., a Delaware corporation (the “Company”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and Morgan Stanley & Co. Incorporated (“Morgan Stanley”), acting on behalf of the several parties named in Schedule A to the Purchase Agreement (as defined below) (collectively, the “Initial Purchasers”).
EXHIBIT 7.3 AGREEMENT REGARDING STOCK TRANSFER RESTRICTIONS THIS AGREEMENT REGARDING STOCK TRANSFER RESTRICTIONS is entered into as of August 6, 1997 by and between Progenitor, Inc., a Delaware corporation ("Progenitor") and Amgen Inc., a Delaware...Agreement Regarding • August 22nd, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
BY AND BETWEEN AMGEN,Assignment and License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
WITNESSETH: ----------Product License Agreement • August 1st, 2000 • Amgen Inc • Biological products, (no disgnostic substances) • California
Annex B PERFORMANCE UNIT AGREEMENT __________________, Amgen Inc. Grantee: On this __ day of _______________ (the "Grant Date"), Amgen Inc., a Delaware corporation (the "Company"), pursuant to its Performance Award Program (the "Program") which...Performance Unit Agreement • March 11th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
